Exercise-induced brain changes in cannabis use disorder: a longitudinal MRI study of a 12-week supervised HIIT program
OBJECTIVE: Cannabis use disorder (CUD) is highly relapsing and has been associated with structural brain alterations (e.g., white matter and cortical thickness) in pathways and regions critical for a healthy brain. The development of non-abstinence-based interventions is essential for restoring structural alterations in CUD. Physical exercise, particularly aerobic exercise, may promote neuroplastic changes in brain structure. METHODS: In this novel randomised, single-blind, comparator-controlled trial, we recruited 59 individuals with CUD (76% classified with severe CUD; median age = 25 years, 22% female, without requiring abstinence during intervention). They were randomly allocated to receive 12-weeks of 45 min, three times/week of either: (i) High Intensity Interval Training (HIIT) aimed to achieve 80% of participants' maximum heart rate (above the lactate release threshold); or (ii) active control Strength and Resistance training (S&R). The main outcome was brain structural organisation (fractional anisotropy and cortical thickness) measured via advanced diffusion and anatomical MRI scans conducted before and after 12 weeks. RESULTS: The HIIT group showed significant increases in FA in the left uncinate fasciculus (p = 0.012) and cortical thickness in the right pars opercularis of the inferior frontal gyrus (p = 0.016), revealed by time-by-group interaction. These exercise-induced changes in white matter and cortical thickness significantly correlated with total hours spent with heart rates > 80% (r = 0.32, p = 0.027 and r = 0.41, p = 0.001) and the time spent above the lactate release threshold (r = 0.27, p = 0.061 and r = 0.40, p = 0.004). CONCLUSION: Overall, a 12-week HIIT exercise intervention, without requiring abstinence from cannabis consumption, can enhance brain plasticity.
Authors
- Warda T Syeda (ORCID: https://orcid.org/0000-0001-6294-622X)
- Edouard Kayayan
- Chao Suo (ORCID: https://orcid.org/0000-0002-9358-6690)
- Karen Caeyenberghs (ORCID: https://orcid.org/0000-0001-7009-6843)
- Murat Yücel (ORCID: https://orcid.org/0000-0002-4705-452X)
- Nadia Solowij (ORCID: https://orcid.org/0000-0002-5222-5637)
- Valentina Lorenzetti (ORCID: https://orcid.org/0000-0002-5917-7068)
- Suzan Maleki
- James P. Coxon (ORCID: https://orcid.org/0000-0003-2351-8489)
- Karyn Richardson
- Sam Hughes
- Dan I. Lubman
- Rebecca A. Segrave
Institutions
- Deakin University (AU)
- The University of Queensland (AU)
- The University of Melbourne (AU)
- University of Wollongong (AU)
- QIMR Berghofer Medical Research Institute (AU)
- Eastern Health (AU)
- Monash University (AU)
- Australian Catholic University (AU)
- Hologic (Germany) (DE)
Publication Details
- Journal
- Molecular Psychiatry
- Published
- 2026-07-02
- DOI
- https://doi.org/10.1038/s41380-026-03720-2
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Wilson Foundation
- Department of Science and Technology, Ministry of Science and Technology, India
- Department of Industry, Innovation and Science, Australian Government
- National Institutes of Health
- Medical Research Council
- National Health and Medical Research Council
- Defence Science and Technology Group